Skip to content
10-Q

Quarterly Report

Enumeral Biomedical Holdings, Inc.

0001615774-17-002592

← back to feed
Filed
May 22, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2017 · May 17, 2017 128.41M sh
Shares Diluted Q1 2017 · Mar 31, 2017 128.36M sh
Shares Diluted Q1 2017 · Mar 31, 2016 52.07M sh
Capex Q1 2017 · Mar 31, 2017 $29.49K
Cash And Equivalents Q1 2017 · Mar 31, 2017 $1.4M
Cash And Equivalents Q1 2017 · Dec 31, 2016 $3.16M
Cash And Equivalents Q1 2017 · Mar 31, 2016 $1.84M
Cash And Equivalents Q1 2017 · Dec 31, 2015 $3.6M
Stockholders Equity Q1 2017 · Mar 31, 2017 $1.96M
Stockholders Equity Q1 2017 · Dec 31, 2016 $3.91M
Current Liabilities Q1 2017 · Mar 31, 2017 $1.03M
Current Liabilities Q1 2017 · Dec 31, 2016 $961.35K
Total Liabilities Q1 2017 · Mar 31, 2017 $1.11M
Total Liabilities Q1 2017 · Dec 31, 2016 $1.04M
Current Assets Q1 2017 · Mar 31, 2017 $1.61M
Current Assets Q1 2017 · Dec 31, 2016 $3.4M
Total Assets Q1 2017 · Mar 31, 2017 $3.07M
Total Assets Q1 2017 · Dec 31, 2016 $4.95M
Eps Diluted Q1 2017 · Mar 31, 2017 −$0.02
Eps Diluted Q1 2017 · Mar 31, 2016 −$0.03
Eps Basic Q1 2017 · Mar 31, 2017 −$0.02
Eps Basic Q1 2017 · Mar 31, 2016 −$0.03
Sga Expense Q1 2017 · Mar 31, 2017 $869.8K
Sga Expense Q1 2017 · Mar 31, 2016 $1.19M
Rd Expense Q1 2017 · Mar 31, 2017 $1.15M
Rd Expense Q1 2017 · Mar 31, 2016 $1.47M
Net Income Q1 2017 · Mar 31, 2017 −$2.01M
Net Income Q1 2017 · Mar 31, 2016 −$1.56M
Operating Income Q1 2017 · Mar 31, 2017 −$2M
Operating Income Q1 2017 · Mar 31, 2016 −$2.23M